Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,474.50
-38.10 (-2.52%)
Oct 24, 2025, 3:30 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 154.26 billion as of October 24, 2025. Its market cap has decreased by -19.73% in one year.
Market Cap
154.26B
Enterprise Value
151.11B
Revenue
11.88B
Ranking
n/a
PE Ratio
43.33
Stock Price
1,474.50
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 154.26B, an increase of 56.40%. That is a compound annual growth rate of 22.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 154.26B | -33.30% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.06T |
| Divi's Laboratories | 1.75T |
| Cipla | 1.34T |
| Apollo Hospitals Enterprise | 1.15T |
| Mankind Pharma | 1.01T |
| Zydus Lifesciences | 1.01T |
| Fortis Healthcare | 828.87B |
| Alkem Laboratories | 663.29B |